GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Antibody Patient ▼ Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG
Patient 4
12
mild
253
IgM
Patient 4
12
mild
1716
IgA
Patient 4
12
mild
507
IgG
Patient 4
12
mild
3871
IgG
Patient 4
12
mild
108
IgM
Patient 4
12
mild
8024
IgA
Patient 4
12
mild
327
IgG
Patient 4
12
mild
67
IgA
Patient 4
12
mild
885
IgG
Patient 4
12
mild
98
Displaying entries 1 - 10 of 4050 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01